BRCA1 and breast cancer: Nevertheless, and in contrast, the prevalence of multifocality/multicentricity in the Northern Ireland cohort of 211 BRCA1/2 mutation carriers was 24.6%, more than double that reported by Vera‐Badillo et al for sporadic breast cancer 1.